FDA Approved: MERCAPTOPURINE — Original Application (Nova Laboratories, Ltd)

View source ↗

Summary

FDA approved mercaptopurine (Purixan) under its original NDA (NDA205919) for the treatment of acute lymphoblastic leukemia, representing Nova Laboratories, Ltd'…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Mercaptopurine (Mercaptopurine)
• Purixan (Mercaptopurine)

Snippet

ORIG AP for MERCAPTOPURINE (MERCAPTOPURINE)